Principles and Practices of Joint Disease Treatment

Diagnosis and Management of Lameness in the Horse

Volumn , Issue , 2003, Pages 746-764

  Caron, John P ^a   Genovese, Ronald L ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Randall Veterinary Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902419885     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-8342-3.50092-9     Document Type: Chapter

References (266)

1. Lippiello L, Yamamoto K, Robinson D, et al. Involvement of prostaglandin from rheumatoid synovium and inhibition of articular cartilage metabolism. Arthritis Rheum 1978, 21:909.
2. Tietz CC, Chrisman OD The effect of salicylate and chloroquine on prostaglandin-induced articular damage in the rabbit knee. Clin Orthop 1975, 108:264.
3. McIlwraith CW General pathobiology of the joint and response to injury. Joint disease in the horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
4. Chin JE, Yin Y Effects of recombinant interleukin-1β on rabbit articular chondrocytes. Arthritis Rheum 1988, 31:1290.
5. Dayer JM, deRochemonteix B, Burrus B, et al. Human recombinant interleukin-1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986, 77:645.
6. May SA, Hooke RA, Lees P Identity of the E-series prostaglandin produced by equine chondrocytes and synovial cells in response to a variety of stimuli. Res Vet Sci 1989, 46:54.
7. Robinson DR, Tashijian HJ, Levine L Prostaglandinstimulated bone resorption by rheumatoid synovia: a possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest 1975, 56:1181.
8. Steinberg JJ, Hubbard JR, Sledge CB Chondrocytemediated breakdown of cartilage. J Rheumatol 1993, 20:325.
9. Mehindate K, al-Daccak R, Aoudjit F, et al. Interleukin-4, transforming growth factor beta 1, and dexamethasone inhibit superantigen-induced prostaglandin E2-dependent collagenase gene expression through their action on cyclooxygenase-2 and cytosolic phospholipase A2. Lab Invest 1996, 75:529.
10. DiBattista JA, Martel-Pelletier J, Fujimoto N, et al. Prostaglandins E2 and E1 inhibit cytokine induced metalloprotease expression in human synovial fibroblasts. Lab Invest 1994, 71:270.
11. Kunkel S, Chensue S Arachidonic acid metabolites regulate interleukin-1 production. Biochem Biophys Res Commun 1985, 128:892.
12. Dingle J Prostaglandins in human cartilage metabolism. J Lipid Med 1993, 6:310.
13. O'Banion MK, Sadowski HB, Winn V, et al. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991, 266:23261.
14. Hla T, Neilson K Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 1992, 89:7384.
15. Robinson DR Regulation of prostaglandin synthesis by antiinflammatory drugs. J Rheumatol 1997, 47:32.
16. Polisson R Nonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selection. Am J Med 1996, 100:31S.
17. Karbowski A Double-blind, parallel comparison of etodolac and indomethacin in patients with osteoarthritis of the knee. Curr Med Res Opin 1991, 12:309.
18. Schnitzer TJ, Constantine G Etodolac (Lodine) in the treatment of osteoarthritis: recent studies. J Rheumatol 1997, 47:23.
19. Prouse PJ, Bevis PJ, Bluhmki E, et al. Evaluation of the safety, tolerability, and efficacy of meloxicam tablets in patients with osteoarthritis. Clin Ther 1996, 18:429.
20. Gilroy DW, Tomlinson A, Greenslade K, et al. The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the rat. Inflammation 1998, 22:509.
21. Bassleer C, Magotteaux J, Geenen V, et al. Effects of meloxicam compared to acetylsalicylic acid in human articular chondrocytes. Pharmacology 1997, 54:49.
22. Bacon PA Etodlac: efficacy in osteoarthritis and effects on chondrocyte function. Rheumatol Int 1990, 10:3.
23. Lees P, McKellar Q, May SA, et al. Pharmacodynamics and pharmacokinetics of carprofen in the horse. Equine Vet J 1994, 26:203.
24. Dawson W, Boot JR, Harvey J, et al. The pharmacology of benoxaprofen with particular reference to effects on lipoxygenase product formation. Eur J Rheumatol Inflamm 1982, 5:61.
25. Abramson S, Korchak H, Ludewig R, et al. Modes of action of aspirin-like drugs. Proc Natl Acad Sci U S A 1985, 82:7227.
26. Dawson J, Lees P, Sedgwick AD Actions of nonsteroidal anti-inflammatory drugs on equine leukocyte movement in vitro. J Vet Pharmacol Ther 1987, 10:150.
27. Clark JO, Clark TP Analgesia. Vet Clin North Am 1999, 15:705.
28. Wyke B The neurology of joints. The joints and synovial fluid 1978, Academic Press, New York. L. Sokoloff (Ed.).
29. Bonica JJ, Yaksh T, Liesbeskind JC, et al. Biochemistry and modulation of nociception and pain. The management of pain 1990, Lea & Febiger, Philadelphia. J.J. Bonica (Ed.).
30. Malmberg AB, Yaksh TL Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclo-oxygenase inhibition. Science 1992, 257:1276.
31. McCormack K, Brune K Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. Drugs 1991, 41:533.
32. Brune K, Menzel-Soglowek S, Zeilhofer HU Differential analgesic effects of aspirin-like drugs. Drugs 1992, 44(5):52.
33. Liles JH, Flecknell PA The use of nonsteroidal antiinflammatory drugs for the relief of pain in laboratory rodents and rabbits. Lab Anim 1992, 26:241.
34. Owens JG, Kamerling SG, Stanton SR, et al. Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses. Am J Vet Res 1996, 57:866.
35. Lees P, May SA, White D Pharmacokinetics and dosage regimens of anti-inflammatory drugs. Ann Rech Vet 1990, 21(1):73S.
36. May SA, Lees P Nonsteroidal anti-inflammatory drugs. Joint disease in the horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
37. Mills PC, Ng JC, Auer DE The effect of inflammation of the disposition of phenylbutazone in thoroughbred horses. J Vet Pharmacol Ther 1996, 19:475.
38. Owens JG, Kamerling SG, Barker SA Pharmacokinetics of ketoprofen in healthy horses and horses with synovitis. J Vet Pharmacol Ther 1995, 18:187.
39. Maitho TE, Lees P, Taylor JB Absorption and pharmacokinetics of phenylbutazone in Welsh mountain ponies. J Vet Pharmacol Ther 1986, 9:26.
40. Welsh JC, Lees P, Stodulski G, et al. Influence of feeding schedule on the absorption of orally administered flunixin in the horse. Equine Vet J Suppl 1992, 11:62.
41. Ghosh P Anti-rheumatic drugs and cartilage. Bailliere's Clin Rheumatol 1988, 2:309.
42. Burkhardt D, Ghosh P Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Semin Arthritis Rheum 1987, 83(5A):3.
43. Dingle JT The effects of NSAID on the matrix of human articular cartilages. Z Rheumatol 1999, 58:125.
44. Rainsford KD, Skerry TM, Chindemi P, et al. Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs. Vet Res Commun 1999, 23:101.
45. Brandt KD Effects of nonsteroidal antiinflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med 1987, 83(5A):29.
46. Palmoski MJ, Brandt KD Effects of some nonsteroidal antiinflammatory drugs on proteoglycan metabolism and organization in canine articular cartilage. Arthritis Rheum 1980, 23:1010.
47. Newman NM, Ling RS Acetabular bone destruction related to nonsteroidal anti-inflammatory drugs. Lancet 1985, 2:11.
48. Rashad S, Hemingway A, Rainsford K, et al. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 1989, 2:519.
49. Doherty M, Holt M, MacMillan P, et al. A reappraisal of "analgesic hip". Ann Rheum Dis 1986, 45:272.
50. Pataki A, Graf HP, Witzemann E Spontaneous osteoarthritis of the knee-joint in C57BL mice receiving chronic oral treatment with NSAID's or prednisone. Agents Actions 1990, 29:210.
51. Calin A Clinical aspects of the effect of NSAID on cartilage. J Rheumatol 1989, 18:43.
52. Ratcliffe A, Rosenwasser MP, Mahmud F The in vivo effects of naproxen on canine experimental osteoarthritic articular cartilage: composition, metalloproteinase activities and metabolism. Agents Actions 1993, 39:207.
53. Pelletier JP, Martel-Pelletier J In vivo protective effects of prophylactic treatment with tiaprofenic acid or intraarticular corticosteroids on osteoarthritic lesions in the experimental dog model. J Rheumatol Suppl 1991, 27:127.
54. Lentini A, Ternai B, Ghosh P Synthetic inhibitors of human granulocyte elastase. Part 4. Inhibition of human granulocyte elastase and cathepsin G by non-steroidal anti-inflammatory drugs (NSAID)s. Biochem Int 1987, 15:1069.
55. Pelletier JP, Martel-Pelletier J Evidence for the involvement of interleukin-1 in human osteoarthritic cartilage degradation: protective effect of NSAID. J Rheumatol 1989, 16:19.
56. Herman JH, Appel AM, Hess EV Modulation of cartilage destruction by select nonsteroidal antiinflammatory drugs: in vitro effect on synthesis and activity of catabolism-inducing cytokines produced by osteoarthritic and rheumatoid synovial tissue. Arthritis Rheum 1987, 30:257.
57. Jolly WT, Whittem T, Jolly AC, et al. The dose-related effects of phenylbutazone and a methylprednisolone acetate formulation (Depo-Medrol) on cultured explants of equine carpal articular cartilage. J Vet Pharmacol Ther 1995, 18:429.
58. May SA, Hooke RE, Lees P The effect of drugs used in the treatment of osteoarthritis on stromelysin (proteoglycanase) of equine synovial cell origin. Equine Vet J Suppl 1988, 6:28.
59. Trotter GW Intra-articular corticosteroids. Joint disease in the horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
60. Gray RG, Tenenbaum J, Gottleib NL Local corticosteroid treatment in rheumatic disorders. Semin Arthritis Rheum 1981, 10:231.
61. Masferrer JL, Seibert K Regulation of prostaglandin synthesis by glucocorticoids. Receptor 1994, 4:25.
62. Hackett RP Intra-articular use of corticosteroids in the horse. J Am Vet Med Assoc 1982, 181:292.
63. Owen RR, Marsh JA, Hallett FR, et al. Intra-articular corticosteroid and exercise-induced arthropathy in a horse. J Am Vet Med Assoc 1984, 184:302.
64. Harkins JD, Carney JM, Tobin T Clinical use and characteristics of the corticosteroids. Vet Clin North Am Equine Pract 1993, 9:543.
65. Fubini SL, Boatwright CE, Todhunter RJ, et al. Effect of intramuscularly administered polysulfated glycosaminoglycan on articular cartilage from equine joints injected with methylprednisolone acetate. Am J Vet Res 1993, 54:1359.
66. Todhunter RJ, Fubini SL, Wootton JA, et al. Effect of methylprednisolone acetate on proteoglycan and collagen metabolism of articular cartilage explants. J Rheumatol 1996, 23:1207.
67. Oegema TR, Behrens F Proteoglycan synthesis in normal and chronically hydrocortisone-suppressed rabbit articular cartilage. Arch Biochem Biophys 1981, 206:277.
68. Chunekamrai S, Krook LP, Lust G, et al. Changes in articular cartilage after intra-articular injections of methylprednisolone acetate in horses. Am J Vet Res 1989, 50:1733.
69. Moskowitz RW, Dabis W, Sammarco J, et al. Experimentally induced corticosteroid arthropathy. Arthritis Rheum 1970, 13:236.
70. Salter RB, Gross A, Hall JH Hydrocortisone arthropathy: an experimental investigation. Can Med J 1967, 97:374.
71. Amano Y, Lee SE, Allison AC Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability. Mol Pharmacol 1993, 43:176.
72. Caron JP, Tardif G, Martel-Pelletier J, et al. Modulation of matrix metalloprotease 13 (collagenase 3) gene expression in equine chondrocytes by IL-1 and corticosteroids. Am J Vet Res 1996, 57:1631.
73. DiBattista JA, Martel-Pelletier J, Wosu LO, et al. Glucocorticoid receptor mediated inhibition of interleukin-1 stimulated neutral metalloprotease synthesis in normal human chondrocytes. J Clin Endocrinol Metab 1991, 72:316.
74. Williams RW, Brandt KD Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damage. Arthritis Rheum 1985, 28:1267.
75. Pelletier JP, Martel-Pelletier J Protective effect of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 1989, 32:181.
76. Pelletier JP, DiBattista JA, Raynauld JP, et al. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis. Lab Invest 1995, 72:578.
77. Borden P, Heller RA Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 1997, 7:159.
78. Richardson DW, Dodge GR Dose-dependent effects of corticosteroids on the expression of matrix related genes in normal and cytokine treated articular chondrocytes. Vet Surg 1998, 27:515. (abstract).
79. Balch HW, Gibson JM, El-Ghobarey AF, et al. Repeated corticosteroid injections into knee joints. Rheumatol Rehabil 1977, 16:137.
80. McCarthy GM, McCarty DJ Intrasynovial corticosteroid therapy. Bull Rheum Dis 1994, 43:2.
81. Roberts WN, Babcock EA, Breitbach SA, et al. Corticosteroid injection in rheumatoid arthritis does not increase rate of total joint arthroplasty. J Rheumatol 1996, 23:1001.
82. Foland JW, McIlwraith CW, Trotter GW, et al. Effect of betamethasone and exercise on equine carpal joints with osteochondral fragments. Vet Surg 1994, 23:369.
83. Kawcak CE, Norrdin RW, Frisbie DD, et al. Effects of osteochondral fragmentation and intra-articular triamcinolone acetonide treatment on subchondral bone in the equine carpus. Equine Vet J 1998, 30:66.
84. Frisbie DD, Kawcak CE, Baxter GM, et al. Effects of 6 alpha-methylprednisolone acetate on an equine osteochondral fragment exercise model. Am J Vet Res 1998, 59:1619.
85. Todhunter RJ, Fubini SL, Vernier-Singer M, et al. Acute synovitis and intra-articular methylprednisolone acetate in ponies. Osteoarthritis Cartilage 1998, 6:94.
86. Derendorf H, Mollman H, Gruner A, et al. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther 1986, 39:313.
87. Kaiser H European experience with intra-articular corticoid therapy. Rheumatology: state of the art 1992, Excerpta Medica, New York. G. Balint, B. Gomor, L. Hodinka (Eds.).
88. Lillich JD, Bertone AL, Schmall LM, et al. Plasma, urine, and synovial fluid disposition of methylprednisolone acetate and isoflupredone acetate after intra-articular administration in horses. Am J Vet Res 1996, 57:187.
89. Autefage A, Alvinerie M, Toutain PL Synovial fluid and plasma kinetics of methylprednisolone and methylprednisolone acetate in horses following intra-articular administration of methylprednisolone acetate. Equine Vet J 1986, 18:193.
90. Leardini G, Mattara L, Franceschini M, et al. Intra-articular treatment of knee osteoarthritis: a comparative study between hyaluronic acid and 6-methyl prednisolone acetate. Clin Exp Rheumatol 1991, 9:375.
91. Tulamo RM, Bramlage, Gabel AA The influences of corticosteroids on sequential clinical and synovial fluid parameters in joints with acute infectious arthritis in the horse. Equine Vet J 1989, 21:332.
92. Howard RD, McIlwraith CW Hyaluronan and its use in the treatment of equine joint disease. Joint disease in the horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
93. Peyron JG Intra-articular hyaluronan injections in the treatment of osteoarthritis: state-of-the art review. J Rheumatol 1993, 20(39):10.
94. Dougados M, Nguyen M, Listrat V, et al. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1993, 1:97.
95. Adams ME, Atkinson MH, Lussier AJ, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 1995, 3:213.
96. Cannon JH Clinical evaluation of intra-articular sodium hyaluronate in the thoroughbred horse. J Equine Vet Sci 1985, 5:147.
97. Ruth DT, Swites BJ Comparison of the effectiveness of intra-articular hyaluronic acid and conventional therapy for the treatment of naturally occurring arthritic conditions in horses. Equine Pract 1985, 7:25.
98. Galley RH The use of hyaluronic acid in the racehorse. Proc Am Assoc Equine Pract 1986, 24:345.
99. Gotoh S, Onaya J, Abe M, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis 1993, 52:817.
100. Forrester JV, Wilkinson PC Inhibition of leukocyte locomotion by hyaluronic acid. J Cell Sci 1981, 48:315.
101. Pisko EJ, Turner RA, Soderstrom LP, et al. Inhibition of neutrophil phagocytosis and enzyme release by hyaluronic acid. Clin Exp Rheumatol 1983, 1:41.
102. Anastassiades T, Robertson W Modulation of mitogendependent lymphocyte stimulation by hyaluronic acid. J Rheumatol 1984, 11:729.
103. Tobetto K, Nakai K, Akatsuka M, et al. Inhibitory effects of hyaluronan on neutrophil-mediated cartilage degradation. Connect Tissue Res 1994, 29:181.
104. Ghosh P The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid. Clin Exp Rheumatol 1994, 12:75.
105. Ghosh P, Read R, Armstrong S, et al. The effects of intraarticular administration of hyaluronan in a model of early osteoarthritis in sheep. I. Gait analysis and radiological and morphological studies. Semin Arthritis Rheum 1993, 22(1):18.
106. Ghosh P, Read R, Numata Y, et al. The effects of intraarticular administration of hyaluronan in a model of early osteoarthritis in sheep. II. Cartilage composition and proteoglycan metabolism. Semin Arthritis Rheum 1993, 22(1):31.
107. Hope N, Ghosh P, Taylor TK, et al. Effects of intraarticular hyaluronan on matrix changes induced in the lateral meniscus by total medial meniscectomy and exercise. Semin Arthritis Rheum 1993, 22(1):43.
108. Balazs EA, Briller SO, Denlinger JL Na-hyaluronate molecular size variations in equine and human arthritic synovial fluids and the effect on phagocytic cells. Semin Arthritis Rheum 1981, 11(1):141.
109. Dahl LB, Dahl IM, Engstrom Laurent A, et al. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985, 44:817.
110. Tulamo RM, Heiskanen J, Salonen M, et al. Concentration and molecular weight distribution of hyaluronate in synovial fluid from clinically normal horses and horses with diseased joints. Am J Vet Res 1994, 55:710.
111. Lynch TM, Caron JP, Arnoczky SP, et al. Influence of exogenous hyaluronan on synthesis of hyaluronan and collagenase by equine synoviocytes. Am J Vet Res 1998, 59:888.
112. Frean SP, Abraham LA, Lees P In vitro stimulation of equine articular cartilage proteoglycan synthesis by hyaluronan and carprofen. Res Vet Sci 1999, 67:183.
113. Shimazu A, Jikko A, Iwamoto M, et al. Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Rheum 1993, 36:247.
114. Morris EA, Wilcon S, Treadwell BV Inhibition of interleukin-1-mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate. Am J Vet Res 1992, 53:1977.
115. Frean SP, Gettinby G, May SA, et al. Influence of interleukin-1 beta and hyaluronan on proteoglycan release from equine navicular hyaline cartilage and fibrocartilage. J Vet Pharmacol Ther 2000, 23:67.
116. 2 production in human osteoarthritic synovial cells. Agents Actions 1992, 37:155.
117. Frean SP, Lees P Effects of polysulfated glycosaminoglycan and hyaluronan on prostaglandin E2 production by cultured equine synoviocytes. Am J Vet Res 2000, 61:499.
118. Larsen NE, Lombard KM, Parent EG, et al. Effect of hylan on cartilage and chondrocyte cultures. J Orthop Res 1992, 10:23.
119. Clegg PD, Jones MD, Carter SD The effect of drugs commonly used in the treatment of equine articular disorders on the activity of equine matrix metalloproteinase-2 and 9. J Vet Pharmacol Ther 1998, 21:406.
120. Heldin P, Laurent TC, Heldin CE Effects of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J 1989, 258:919.
121. Pulkki K The effects of synovial fluid macrophages and interleukin-1 on hyaluronic acid synthesis by normal synovial fibroblasts. Rheumatol Int 1986, 6:121-125.
122. Lindholm A, Roneus B, Lindblad G, et al. Hyaluronan turnover in the synovial fluid in metacarpophalangeal and middle carpal joints in standardbred horses. Acta Vet Scand 1996, 37:147.
123. Brown TJ, Laurent UB, Fraser JR Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol 1991, 76:125.
124. Fraser JR, Kimpton WG, Pierscionek BK, et al. The kinetics of hyaluronan in normal and acutely inflamed synovial joints: observations with experimental arthritis in sheep. Semin Arthritis Rheum 1993, 22(1):9.
125. Abatangelo G, Botti P, Del Bue M, et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. I. Biochemical results. Clin Orthop 1989, 241:278.
126. Schiavinato A, Lini E, Guidolin D, et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II. Morphological findings. Clin Orthop 1989, 241:286.
127. Armstrong S, Read R, Ghosh P The effects of intraarticular hyaluronan on cartilage and subchondral bone changes in an ovine model of early osteoarthritis. J Rheumatol 1994, 21:680.
128. Sakakibara Y, Takayuki M, Iwata H, et al. Effect of highmolecular-weight sodium hyaluronate on immobilized rabbit knee. Clin Orthop 1994, 299:282.
129. Aviad AD, Arthur RM, Brenick VA, et al. The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it?. J Rheumatol 1994, 21:297.
130. Phillips MW Clinical trial comparison of intra-articular sodium hyaluronate products in the horse. J Equine Vet Sci 1989, 9:39.
131. Tew WP Sodium hyaluronate and the treatment of equine joint disorders. Proc Am Assoc Equine Pract 1984, 30:67.
132. Aviad AD, Arthur RM, Brenick VA, et al. Synacid vs. Hylartin V in equine joint disease. J Equine Vet Sci 1988, 8:112.
133. Kawcak CE, Frisbie DD, Trotter GW, et al. Effects of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation. Am J Vet Res 1997, 58:1132.
134. Henderson KJ, Edwards JC, Worrall JG Expression of CD44 in normal and rheumatoid synovium and cultured synovial fibroblasts. Ann Rheum Dis 1994, 53:729.
135. Haynes BF, Hale LP, Patton KL Measurement of an adhesion molecule as an indicator of inflammatory disease activity: up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum 1991, 34:1434.
136. Trotter GW Polysulfated glycosaminoglycan (Adequan). Joint disease in the horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
137. Todhunter RJ, Lust G Polysulfated glycosaminoglycan in the treatment of osteoarthritis. J Am Vet Med Assoc 1994, 204:1245.
138. Raatikainen T, Väänänen K, Tamelander G Effect of glycosaminoglycan polysulfate on chondromalacia patellae: a placebo-controlled 1-year study. Acta Orthop Scand 1990, 61:443.
139. Rejholec V Long-term studies of antiosteoarthritic drugs: an assessment. Semin Arthritis Rheum 1987, 17:35.
140. Pastinen O, Forsskahl B, Marklund M Local glycosaminoglycan polysulphate injection therapy in osteoarthritis of the horse. Scand J Rheumatol 1988, 17:197.
141. Hamm D, Goldman L, Jones EW Polysulfated glycosaminoglycan: a new intra-articular treatment for equine lameness. Equine Vet Med 1984, 79:811.
142. Hamm D, Jones EW Intra-articular (IA) and intramuscular (IM) treatment of noninfectious equine arthritis (DJD) with polysulfated glycosaminoglycan (PSGAG). J Equine Vet Sci 1988, 8:456.
143. Caron JP, Kaneene JB, Miller R Results of a survey of equine practitioners on the use and perceived efficacy of polysulfated glycosaminoglycan. J Am Vet Med Assoc 1996, 209:1564.
144. Dietmar EG G Effects of glycosaminoglycan-polysulfates and two nonsteroidal anti-inflammatory drugs on prostaglandin E2 synthesis in Chinese hamster ovary cell cultures. Pharmacol Res Commun 1983, 15:709.
145. Jones IL, Fandstrom T Enhanced breakdown of bovine articular cartilage proteoglycans by conditioned synovial medium in-vitro. Arzneimittelforschung 1985, 35:141.
146. Nishikawa H, Mori I, Umemoto J Influences of sulfated glycosaminoglycans on biosynthesis of hyaluronic acid in rabbit knee synovial membrane. Arch Biochem Biophys 1985, 240:146.
147. Smith MM, Ghosh P The effects of some polysulphated polysaccharides on hyaluronate (HA) synthesis by human synovial fibroblasts. Agents Actions 1986, 18:55.
148. Adam M, Krabcova M, Musilova J, et al. Contribution to the mode of action of glycosaminglycan-polysulfate (GAGPS) upon human osteoarthritis cartilage. Arzneimittelforschung 1980, 30:1730.
149. Glade MJ Polysulphated glycosaminoglycan accelerates net synthesis of collagen and glycosaminoglycans by arthritic equine cartilage tissues and chondrocytes. Am J Vet Res 1990, 51:779.
150. Caron JP, Eberhart SW, Nachreiner R Influence of polysulfated glycosaminoglycan on equine articular cartilage in explant culture. Am J Vet Res 1991, 52:1622.
151. Caron JP, Toppin DS, Block JA Polysulfated glycosaminoglycan and osteoarthritic equine cartilage in explant culture. Am J Vet Res 1993, 54:1116.
152. Todhunter RJ, Minor RR, Wootton JA, et al. Effects of exercise and polysulfated glycosaminoglycan on repair of cartilage defects in the equine carpus. J Orthop Res 1993, 11:782.
153. Barr AR, Duance VC, Wotton SF, et al. Influence of intra-articular sodium hyaluronate and polysulphated glycosaminoglycans on the biochemical composition of equine articular surface repair tissue. Equine Vet J 1994, 26:40.
154. Howell DS, Carreno MR, Pelletier JP, et al. Articular cartilage breakdown in a lapine model of osteoarthritis: action of glycosaminoglycan polysulfate ester (GAGPS) on proteoglycan enzyme activity, hexuronate, and cell counts. Clin Orthop 1986, 213:69.
155. Altman RD, Dean DD, Muniz OE, et al. Prophylactic treatment of canine osteoarthritis with glycosaminoglycan polysulfuric acid ester. Arthritis Rheum 1989, 32:759.
156. Mikolikova D, Trnasky K Influence of glycosaminoglycan polysulfate (Arteparon) on lysosomal enzyme release from human polymorphonuclear leukocytes. J Rheumatol 1982, 41:50.
157. Carreno M, Muniz O, Howell D The effect of glycosaminoglycan polysulphate acid ester on articular cartilage in experimental osteoarthritis: Effects on morphological variables of disease severity. J Rheumatol 1986, 13:490.
158. Hannan N, Ghosh P, Bellenger C, et al. Systemic administration of glycosaminoglycan polysulphate (Arteparon) provides partial protection of articular cartilage from damage produced by meniscectomy in the canine. J Orthop Res 1987, 5:47.
159. Michelsson J-E, Forsskahl B The effect of glycosaminoglycan polysulphate on the thickening, stiffening and radiologically detectable osteoarthritis of rabbit knees following immobilization. Curr Ther Res 1985, 37:427.
160. Altman RD, Dean DD, Muniz OE, et al. Therapeutic treatment of canine osteoarthritis with glycosaminoglycan polysulfuric acid ester. Arthritis Rheum 1989, 32:1300.
161. Gustafson SB, McIlwraith CW, Jones RL Comparison of the effect of polysulfated glycosaminoglycan, corticosteroids, and sodium hyaluronate in the potentiation of a subinfective dose of Staphylococcus aureus in the midcarpal joint of horses. Am J Vet Res 1989, 50(12):2014.
162. Burba DJ, Collier MA, Default LE, et al. In vivo kinetic study on uptake and distribution of intramuscular tritiumlabeled polysulfated glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteochondral defect model. J Equine Vet Sci 1993, 13:696.
163. Little C, Ghosh P Potential use of pentosan polysulfate for the treatment of equine joint disease. Joint disease in the horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
164. Raiss RX, Karbowski A, Aigner T, et al. Chondrocytes and antirheumatic drugs. J Rheumatol Suppl 1995, 43:152.
165. Rogachefsky RA, Dean DD, Howell DS, et al. Treatment of canine osteoarthritis with insulin-like growth factor-1 (IGF-1) and sodium pentosan polysulfate. Osteoarthritis Cartilage 1993, 1:105.
166. Smith MM, Ghosh P, Numata Y, et al. The effects of orally administered calcium pentosan polysulfate on inflammation and cartilage degradation produced in rabbit joints by intraarticular injection of a hyaluronatepolylysine complex. Arthritis Rheum 1994, 37:125.
167. Setnikar I, Palmbo R, Canali S, et al. Pharmacokinetics of glucosamine in man. Arzneimittelforschung 1993, 43:1109.
168. Bassleer C, Rovati L, Franchimont P Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 1998, 6:427.
169. Setnikar I Antireactive properties of "chondroprotective" drugs. Int J Tissue React 1992, 14:253.
170. Bassleer C, Henrotin Y, Franchimont P In-vitro evaluation of drugs proposed as chondroprotective agents. Int J Tissue React 1992, 14:231.
171. Piperno M, Reboul P, Hellio Le Graverand MP, et al. Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro. Osteoarthritis Cartilage 2000, 8:207.
172. Fenton JI, Chlebek-Brown KA, Peters TA, et al. Glucosamine reduces equine articular cartilage degradation in explant culture. Osteoarthritis Cartilage 2000, 8:258.
173. Fenton JI, Chlebek-Brown KA, Peters TA, et al. Effects of glucosamine derivatives on equine articular degradation in explant culture. Osteoarthritis Cartilage 2000, 8:444.
174. Gouze J-N, Borji D, Gulberti S, et al. Interleukin-1β down-regulates the expression of glucurononsyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis. Arthritis Rheum 2001, 44:351.
175. Ronca F, Palmieri L, Panicucci P, et al. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 1998, 6(A):14.
176. Conte A, De Bernardi M, Palmieri L, et al. Metabolic fate of exogenous chondroitin sulfate in man. Arzneimittelforschung 1991, 41:768.
177. Bassleer CT, Combal JP, Bougaret S, et al. Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage 1998, 6:196.
178. Nerucci F, Fioravanti A, Cicero MR, et al. Effects of chondroitin sulfate and interleukin-1beta on human chondrocyte cultures exposed to pressurization: a biochemical and morphological study. Osteoarthritis Cartilage 2000, 8:279.
179. Omata T, Segawa Y, Itokazu Y, et al. Effects of chondroitin sulfate-C on bradykinin-induced proteoglycan depletion in rats. Arzneimittelforschung 1999, 49:577.
180. Uebelhart D, Thonar EJ, Zhang J, et al. Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit. Osteoarthritis Cartilage 1998, 6(A):6.
181. Palmieri L, Conte A, Giovannini L, et al. Metabolic fate of exogenous chondroitin sulfate in the experimental animal. Arzneimittelforschung 1990, 40:319.
182. Baici A, Horler D, Moser B, et al. Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate. Rheumatol Int 1993, 13:81.
183. Müller-Fassbender H, Bach G, Haase W, et al. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 1994, 2:61.
184. Delafuente JC Glucosamine in the treatment of osteoarthritis. Rheum Dis Clin North Am 2000, 26:1.
185. Deal CL, Moskowitz RW Nutraceuticals as therapeutic agents in osteoarthritis: the role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999, 25:379.
186. Leeb BF, Schweitzer H, Montag KA, et al. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 2000, 27:205.
187. McAlindon TE, LaValley MP, Gulin JP, et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000, 283:1469.
188. Leffler CT, Philippi AF, Leffler SG, et al. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med 1999, 164:85.
189. Hansen RR Oral glycosaminoglycans in the treatment of degenerative joint disease in horses. Equine Pract 1996, 18:18.
190. Hague BA, Honnas CM, Simpson RB, et al. Evaluation of skin bacterial flora before and after aseptic preparation of clipped and nonclipped arthrocentesis sites in horses. Vet Surg 1997, 26:121.
191. Centeno LM, Moore ME Preferred intraarticular corticosteroids and associated practice: a survey of members of the American College of Rheumatology. Arthritis Care Res 1994, 7:151.
192. Murray RC, DeBowes RM, Gaughn EM, et al. The effects of intra-articular methylprednisolone and exercise on the mechanical properties of articular cartilage in the horse. Osteoarthritis Cartilage 1998, 6:106.
193. Farquhar T, Todhunter RJ, Fubini SL, et al. Effect of methylprednisolone and mechanical loading on canine articular cartilage in explant culture. Osteoarthritis Cartilage 1996, 4:55.
194. Frisbie DD, Kawcak CE, Trotter GW, et al. Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model. Equine Vet J 1997, 29:349.
195. White KK, Hodgson DR, Hancock D, et al. Changes in equine carpal joint synovial fluid in response to the injection of two local anesthetic agents. Cornell Vet 1989, 79:25.
196. McIlwraith CW Diagnostic and surgical arthroscopy in the horse 1990, Lea & Febiger, Philadelphia. ed 2.
197. McIlwraith CW, Bramlage LR Surgical treatment of joint injury. Joint disease in the horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
198. Moore RM, Schneider RK Arthroscopic findings in the carpal joints of lame horses without radiographically visible abnormalities: 41 cases (1986-1991). J Am Vet Med Assoc 1995, 206:1741.
199. Kawcak CE, McIlwraith CW Proximodorsal first phalanx osteochondral chip fragments in 320 horses. Equine Vet J 1994, 26:392.
200. Chang RW, Falconer J, Stulberg SD, et al. A randomized, controlled trial of arthroscopic surgery versus closedneedle joint lavage for patients with osteoarthritis of the knee. Arthritis Rheum 1993, 36:289.
201. Reardon EV, Tuggle CJ, Clough JD, et al. A prospective study of the use of tidal lavage (irrigation) in patients with osteoarthritis of the knee. Arthritis Rheum 1989, 32(4):S139. (abstract).
202. Ike RW, Arnold WJ, Rothschild EW, et al. Tidal irrigation versus conservative medical management in patients with osteoarthritis of the knee: a prospective randomized study. J Rheumatol 1992, 19:772.
203. Gaustad G, Dolvik NI, Larsen S Comparison of intraarticular injection of 2 ml of 0.9% NaCl solution with rest alone for treatment of horses with traumatic arthritis. Am J Vet Res 1999, 60:1117.
204. Pool RR, Meagher DM Pathologic findings and pathogenesis of racetrack injuries. Vet Clin North Am Equine Pract 1990, 6:1.
205. Pool RR Pathologic manifestations of joint disease in the athletic horse. Joint disease in the horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
206. Todhunter RJ, Minor RR, Wootton JA, et al. Effects of exercise and polysulfated glycosaminoglycan on repair of cartilage defects in the equine carpus. J Orthop Res 1993, 11:782.
207. Barr AR, Duance VC, Wotton SF, et al. Influence of intra-articular sodium hyaluronate and polysulphated glycosaminoglycans on the biochemical composition of equine articular surface repair tissue. Equine Vet J 1994, 26:40.
208. McIlwraith CW, Yovich JV, Martin GS Arthroscopic surgery for the treatment of osteochondral chip fractures in the equine carpus. J Am Vet Med Assoc 1987, 191:531.
209. Mitchell N, Shepard N Healing of articular cartilage in intra-articular fractures in rabbits. J Bone Joint Surg Am 1980, 62:628.
210. Zekas LJ, Bramlage LR, Embertson RM, et al. Results of treatment of 145 fractures of the third metacarpal/metatarsal condyles in 135 horses (1986-1994). Equine Vet J 1999, 31:309.
211. Equine fracture repair 1996, WB Saunders, Philadelphia. A.J. Nixon (Ed.).
212. Fackelman GE, Nunamaker DM Manual of internal fixation in the horse 1982, Springer-Verlag, New York.
213. Newman AP Synovectomy. Textbook of rheumatology 1993, WB Saunders, Philadelphia. ed 4. W.N. Kelley, E.D. Harris, S. Ruddy (Eds.).
214. Ishikawa H, Ohno O, Hirohata K Long-term results of synovectomy in rheumatoid patients. J Bone Joint Surg Am 1986, 68:198.
215. Doets H, Bierman B, Soesbergen R Synovectomy of the rheumatoid knee does not prevent deterioration. Acta Orthop Scand 1989, 60:523.
216. Kalunian KC, Moreland LW, Ike RW Arthroscopy. Arthritis and allied conditions: a textbook of rheumatology 1997, Williams & Wilkins, Baltimore. ed 13. W.J. Koopman (Ed.).
217. Jones DL, Barber SM, Doige CE Synovial fluid and clinical changes after arthroscopic partial synovectomy of the equine middle carpal joint. Vet Surg 1993, 22:524.
218. Jones DL, Barber SM, Jack SW, et al. Morphological effects of arthroscopic partial synovectomy in horses. Vet Surg 1994, 23:231.
219. Theoret CL, Barber SM, Moyana T, et al. Repair and function of synovium after arthroscopic synovectomy of the dorsal compartment of the equine antebrachiocarpal joint. Vet Surg 1996, 25:142.
220. Clayton HM, Theoret CL, Barker SM, et al. Effects of carpal synovectomy on stride kinematics of trotting horses. Vet Comp Orthop Traumatol 1998, 11:80.
221. Bertone AL, Davis DM, Cox HU, et al. Arthrotomy versus arthroscopy and partial synovectomy for treatment of experimentally induced infectious arthritis in horses. Am J Vet Res 1992, 53:585.
222. Roneus B, Andersson AM, Ekman S Racing performance in standardbred trotters with chronic synovitis after partial arthroscopic synovectomy in the metacarpophalangeal, metatarsophalangeal and intercarpal (midcarpal) joints. Acta Vet Scand 1997, 38:87.
223. Archer RM, Schneider RK, Lindsay WA, et al. Arthrodesis of the equine distal tarsal joints by perforated stainless steel cylinders. Equine Vet J Suppl 1988, 6:125.
224. Martin GS, McIlwraith CW, Turner AS, et al. Long-term results and complications of proximal interphalangeal arthrodesis in horses. J Am Vet Med Assoc 1984, 184:1136.
225. Doran RE, White NA, Allen D Use of a bone plate for treatment of middle phalangeal fractures in horses: seven cases (1979-1984). J Am Vet Med Assoc 1987, 191:575.
226. Caron JP, Fretz PB, Bailey JV, et al. Proximal interphalangeal arthrodesis in the horse: a retrospective study and a modified screw technique. Vet Surg 1990, 19:196.
227. Archer RM, Schneider RK, Lindsay WA, et al. Arthrodesis of the equine distal tarsal joints by perforated stainless steel cylinders. Equine Vet J Suppl 1988, 6:125.
228. Bohanon TC, Schneider RK, Weisbrode SE Fusion of the distal intertarsal and tarsometatarsal joints in the horse using intraarticular sodium monoiodoacetate. Equine Vet J 1991, 23:289.
229. Sammut EB, Kannegeiter NF Use of sodium monoiodoacetate to fuse the distal hock joints in horses. Aust Vet J 1995, 72:25.
230. MacDonald DG, Bailey JV, Fowler JD Arthrodesis of the scapulohumeral joint in a horse. Can Vet J 1995, 36:312.
231. Schneider RK, Bramlage LR, Hardy J Arthrodesis of the distal interphalangeal joint in two horses using three parallel 5.5-mm cortical screws. Vet Surg 1993, 22:122.
232. Bertone AL, Schneiter HL, Turner AS, et al. Pancarpal arthrodesis for treatment of carpal collapse in the adult horse: a report of two cases. Vet Surg 1989, 18:353.
233. Arighi M, Miller CR, Pennock PW Arthrodesis of the scapulohumeral joint in a miniature horse. J AmVet Med Assoc 1987, 191:713.
234. McIlwraith CW, Nixon AJ Joint resurfacing: attempts at repairing articular cartilage defects. Joint disease in the horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
235. Sams AE, Nixon AJ Chondrocyte-laden collagen scaffolds for resurfacing extensive articular cartilage defects. Osteoarthritis Cartilage 1995, 3:47.
236. Howard RD, McIlwraith CW, Powers BE, et al. Long term fate and effects of athletic exercise on sternal cartilage autografts used for repair of large osteochondral defects in horses. Am J Vet Res 1994, 55:1158.
237. Vachon A, Bramlage LR, Gabel AA Evaluation of the repair process of cartilage defects of the equine third carpal bone with and without subchondral bone perforation. Am J Vet Res 1986, 47:2637.
238. Shamis LD, Bramlage LR, Gabel AA, et al. Effect of subchondral drilling on repair of partial-thickness cartilage defects of third carpal bones in horses. Am J Vet Res 1989, 50:290.
239. Rodrigo JJ, Steadman RJ, Silliman JF, et al. Improvement of full-thickness chondral defect healing in the human knee after debridement and microfacture using continuous passive motion. Am J Knee Surg 1994, 7:109.
240. Minas T, Nehrer S Current concepts in the treatment of articular cartilage defects. Orthopaedics 1997, 20:525.
241. Steadman JR Use of microfracture for chondral resurfacing: techniques, procedures and ongoing research. Proc Am Coll Vet Surg Symp 1996, 6:124.
242. Frisbie D, Trotter GW, Powers BE, et al. Arthroscopic subchondral bone plate microfracture augments healing of large osteochondral defects in the radial carpal bone and medial femoral condyle of horses. Vet Surg 1997, 26:414. (abstract).
243. Nixon AJ, Sams AE, Lust G, et al. Temporal matrix synthesis and histologic features of a chondrocyte-laden porous collagen cartilage analogue. Am J Vet Res 1993, 54:349.
244. Hendrickson DA, Nixon AJ, Erb HN Phenotype and biological activity of neonatal equine chondrocytes cultured in a three-dimensional fibrin matrix. Am J Vet Res 1994, 55:410.
245. Metsaranta M, Kujala UM, Pelliniemi L, et al. Evidence for insufficient chondrocytic differentiation during repair of full-thickness defects of articular cartilage. Matrix Biol 1996, 15:39.
246. Fortier L, Nixon AJ, Mohammed HO, et al. Altered biological activity of equine chondrocytes cultured in a three-dimensional fibrin matrix and supplemented with transforming growth factor β-1. Am J Vet Res 1997, 58:66.
247. Hunziker EB, Rosenberg L Articular cartilage repair. Arthritis and allied conditions: a textbook of rheumatology 1997, Williams & Wilkins, Baltimore. ed 13. W.J. Koopman (Ed.).
248. Andrews HJ, Plumpton TA, Harper GP, et al. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions 1992, 37:147.
249. Carmichael DF, Stricklin GP, Stuart JM Systemic administration of TIMP in the treatment of collageninduced arthritis in mice. Agents Actions 1989, 27:378.
250. Gordon JL, Drummond AH, Galloway WA Metalloproteinase inhibitors as therapeutics. Clin Exp Rheumatol 1993, 11(8):S91.
251. Nixon JS, Bottomley KM K, Broadhurst MJ, et al. Potent collagenase inhibitors prevent interleukin-1 induced cartilage degradation in vitro. Int J Tissue React 1991, 13:237.
252. Henderson B, Thompson RC, Hardingham T Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine 1991, 3:246.
253. Caron JP, Fernandez JC, Martel-Pelletier J, et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 1996, 39:1535.
254. Piguet PF, Grau GE, Vesin C, et al. Evolution of collagen arthritis in mice is arrested by treatment with antitumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 1992, 77:510.
255. Wooley PH, Dutcher J, Widmer MB Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol 1993, 151:6602.
256. Vannier E, Miller EC, Dinarello CA Coordinated antiinflammatory effects of interleukin-4 suppresses interleukin-1 production but up-regulates gene expression and synthesis of interleukin-1 receptor antagonist. Proc Natl Acad Sci U S A 1992, 89:4076.
257. Trippel SB Growth factor actions on articular cartilage. J Rheumatol 1995, 43:129.
258. Toolan BC, Frenkel SR, Pachence JM Effects of growthfactor-enhanced culture on a chondrocyte-collagen implant for cartilage repair. J Biomed Mater Res 1996, 1:273.
259. Evans CH, Ghivizzani SC, Kang R, et al. Gene therapy for rheumatic diseases. Arthritis Rheum 1999, 42:1.
260. Evans CH, Robbins PD Potential treatment of osteoarthritis by gene therapy. Rheum Dis Clin North Am 1999, 25:333.
261. Hung GL, Galea-Lauri J, Mueller GM, et al. Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther 1994, 1:64.
262. Pelletier JP, Caron JP, Evans C, et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997, 40:1012.
263. Frisbie DD, Ghivizzani S, Robbins PD, et al. Dose titration of interleukin-1 receptor antagonist delivered using gene transfer to normal equine joints. Vet Surg 2000, 29:282. (abstract).
264. Frisbie DD, Ghivizzani S, Evans CH, McIlwraith CW Interleukin-1 receptor antagonist (IL-1Ra) delivered using adenoviral mediated gene transfer for the treatment of experimental joint disease. Vet Surg 2000, 29:282. (abstract).
265. Arai Y, Kubo T, Kobayashi K, et al. Adenovirus vectormediated gene transduction to chondrocytes: in vitro evaluation of therapeutic efficacy of transforming growth factor β1 and heat shock protein 70 gene transduction. J Rheumatol 1997, 24:1787.
266. Smith P, Shuler FD, Georgescu HI, et al. Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum 2000, 43:1156.